{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:20:23Z","timestamp":1792707623736,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jgo.2025.102839","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T06:52:32Z","timestamp":1766299952000},"page":"102839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Review of current best practice in radiation oncology for older adults with cancer: Updates from the International Society of Geriatric Oncology (SIOG) Task Force"],"prefix":"10.1016","volume":"17","author":[{"given":"Lucinda","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niluja","family":"Thiruthaneeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"O'Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"VanderWalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthea","family":"Cree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Starup","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Simcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2025.102839_bb0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.12968\/hmed.2019.80.5.252","article-title":"Geriatric oncology: assessing the needs of older people with cancer","volume":"80","author":"O\u2019Hanlon","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"issue":"11","key":"10.1016\/j.jgo.2025.102839_bb0015","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/annonc\/mdu104","article-title":"Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force","volume":"25","author":"Kunkler","year":"2014","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2025.102839_bb0020","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2022.04.030","article-title":"An international expert delphi concensus to develop dedicated geriatric radiation oncology curriculum learning outcomes","volume":"113","author":"Morris","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.jgo.2025.102839_bb0025","first-page":"362","article-title":"Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology","volume":"67","author":"Ethun","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2022.10.002","article-title":"Radiotherapy utilisation rates for patients with cancer as a function of age: a systematic review","volume":"14","author":"Mackenzie","year":"2023","journal-title":"J Geriatr Oncol"},{"issue":"24","key":"10.1016\/j.jgo.2025.102839_bb0035","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.6004\/jnccn.2014.0009","article-title":"Senior adult oncology, version 2.2014: clinical practice guidelines in oncology","volume":"12","author":"Hurria","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.jgo.2025.102839_bb0045","first-page":"87","article-title":"Wieland Comprehensive geriatric assessment: toward understanding its efficacy","volume":"1","author":"Rubenstein","year":"1989","journal-title":"Aging"},{"issue":"13","key":"10.1016\/j.jgo.2025.102839_bb0050","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jgo.2025.102839_bb0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.2002.20.2.494","article-title":"Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study","volume":"20","author":"Repetto","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0060","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jgo.2021.11.002","article-title":"International efforts in geriatric radiation oncology","volume":"13","author":"Naseer","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2025.102839_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115060","article-title":"Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study","volume":"9","author":"Soubeyran","year":"2014","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.jgo.2025.102839_bb0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2025.102839_bb0075","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(22)00270-4","article-title":"Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs","volume":"23","author":"Bray","year":"2022","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00351-X","article-title":"Radiotherapy resources in Africa: an International Atomic Energy Agency update and analysis of projected needs","volume":"22","author":"Elmore","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0085","series-title":"Geriatric oncology","article-title":"Geriatric oncology in tropical and developing countries","author":"Droz","year":"2017"},{"key":"10.1016\/j.jgo.2025.102839_bb0090","article-title":"Barriers and facilitators for the implementation of geriatric oncology principles in Mexico: a mixed-methods study","volume":"8","author":"Verduzco-Aguirre","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2025.102839_bb0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/CRST.CRST_150_20","article-title":"Geriatric oncology landscape in India \u2013 current scenario and future projections","volume":"3","author":"Parikh","year":"2020","journal-title":"Cancer Res Stat Treat"},{"issue":"5","key":"10.1016\/j.jgo.2025.102839_bb0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1634\/theoncologist.2019-0853","article-title":"Inclusive cancer care: rethinking patients living with HIV and cancer","volume":"25","author":"Corrigan","year":"2020","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12877-023-04248-8","article-title":"Impact of cancer diagnosis and treatment: a qualitative analysis of strains, resources and coping strategies among elderly patients in a rural setting in Ghana","volume":"23","author":"Mensah","year":"2023","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jgo.2025.102839_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.breast.2022.04.003","article-title":"Global guidelines for breast cancer screening: a systematic review","volume":"64","author":"Ren","year":"2022","journal-title":"Breast"},{"issue":"7","key":"10.1016\/j.jgo.2025.102839_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30741-5","article-title":"Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)","volume":"22","author":"Biganzoli","year":"2021","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.jgo.2025.102839_bb0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2025.102839_bb0125","article-title":"Not too little, not too much: optimizing more versus less locoregional treatment for older patients with breast cancer","volume":"43","author":"Tseng","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijrobp.2022.12.028","article-title":"Cost-effectiveness analysis of ultra-hypofractionated whole breast radiation therapy alone versus hormone therapy alone or combined treatment for low-risk ER-positive early stage breast cancer in women aged 65 years and older","volume":"116","author":"Ward","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jgo.2025.102839_bb0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jgo.2020.07.013","volume":"12","author":"Meattini","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0140","first-page":"112","article-title":"Omission of postoperative radiation after breast conserving surgery: a progressive paradigm shift towards precision medicine","volume":"21","author":"Franco","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"issue":"7","key":"10.1016\/j.jgo.2025.102839_bb0145","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1470-2045(25)00194-9","article-title":"Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial","volume":"26","author":"Kirby","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.breast.2023.04.007","article-title":"Partial breast irradiation","volume":"69","author":"Meattini","year":"2023","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2022.05.019","article-title":"Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the COVID-19 pandemic: a population-based cohort study of older women in England and Wales","volume":"34","author":"Gannon","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2023.05.016","article-title":"Variation in rates of post-mastectomy radiotherapy among women with early invasive breast cancer in England and Wales: a population-based cohort study","volume":"35","author":"Miller","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"10.1016\/j.jgo.2025.102839_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054365","volume":"11","author":"Goyal","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jgo.2025.102839_bb0170","author":"UK C"},{"key":"10.1016\/j.jgo.2025.102839_bb0175","first-page":"147","article-title":"Cancer in the elderly","volume":"117","author":"Berger","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"10","key":"10.1016\/j.jgo.2025.102839_bb0180","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2025.102839_bb0185","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijrobp.2023.08.027","article-title":"5-year outcomes from PACE B: an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) vs. conventionally fractionated or moderately hypo fractionated external beam radiotherapy for localized prostate cancer","volume":"117","author":"van As","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"issue":"10196","key":"10.1016\/j.jgo.2025.102839_bb0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2025.102839_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tipsro.2020.09.004","article-title":"Practical brachytherapy solutions to an age-old quandary","volume":"16","author":"Thiruthaneeswaran","year":"2020","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2019.06.018","article-title":"Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: a quality of life analysis of two prospective clinical trials","volume":"140","author":"Alayed","year":"2019","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2025.102839_bb0210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","article-title":"Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials","volume":"22","author":"Choudhury","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijrobp.2017.01.239","article-title":"Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment","volume":"98","author":"Hafeez","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.jgo.2025.102839_bb0220","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2022.06.017","article-title":"The role of stereotactic ablative body radiotherapy in renal cell carcinoma","volume":"82","author":"Ali","year":"2022","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0225","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1470-2045(24)00020-2","article-title":"Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2025.102839_bb0230","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2025.102839_bb0235","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminoncol.2018.06.002","article-title":"Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly","volume":"45","author":"Shinde","year":"2018","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2025.102839_bb0240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.prro.2023.04.004","article-title":"Treatment of oligometastatic non-small cell lung cancer: an ASTRO\/ESTRO clinical practice guideline","volume":"13","author":"Iyengar","year":"2023","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41416-020-01128-5","article-title":"Metastasis-directed therapy for oligometastasis and beyond","volume":"124","author":"Beckham","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2025.102839_bb0250","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2021.03.025","article-title":"ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology","volume":"159","author":"Corradini","year":"2021","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.jgo.2025.102839_bb0255","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(12)70139-0","article-title":"Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)","volume":"13","author":"Atagi","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0260","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/0284186X.2014.958529","article-title":"Age dependent prognosis in concurrent chemo-radiation of locally advanced NSCLC","volume":"54","author":"Hansen","year":"2015","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2025.102839_bb0265","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2025.102839_bb0270","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jtho.2023.01.012","article-title":"Treatment outcomes of older participants in a randomized trial comparing two schedules of twice-daily thoracic radiotherapy in limited-stage SCLC","volume":"18","author":"Killingberg","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.889161","article-title":"Risk factors for brain metastases in patients with small cell lung cancer: a systematic review and meta-analysis","volume":"12","author":"Zeng","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2025.102839_bb0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3892\/mco.2021.2418","article-title":"Rectal cancer treatment and outcomes in elderly patients treated with curative intent","volume":"15","author":"Kang","year":"2021","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0285","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jgo.2021.10.008","article-title":"The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials","volume":"13","author":"VanderWalde","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2025.102839_bb0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/JCO.22.00184","article-title":"Neoadjuvant chemotherapy, excision, and observation for early rectal cancer: the phase II NEO trial (CCTG CO.28) primary end point results","volume":"41","author":"Kennecke","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2025.102839_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-7568(22)00239-2","volume":"3","author":"Gilbert","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"10.1016\/j.jgo.2025.102839_bb0300","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ijrobp.2017.12.261","article-title":"Decision-making strategy for rectal cancer management using radiation therapy for elderly or comorbid patients","volume":"100","author":"Wang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2025.102839_bb0310","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2025.102839_bb0315","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jgo.2025.102839_bb0320","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1200\/JCO.23.00903","article-title":"Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048)","volume":"41","author":"Basch","year":"2023","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jgo.2025.102839_bb0325","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0330","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12905-021-01571-3","article-title":"Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007\u20132017: findings from the global burden of disease study 2017","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Womens Health"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0335","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.brachy.2018.12.002","article-title":"Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer","volume":"18","author":"Ma","year":"2019","journal-title":"Brachytherapy"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0340","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41415-022-5166-x","article-title":"Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors","volume":"233","author":"Gormley","year":"2022","journal-title":"Br Dent J"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0345","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1634\/theoncologist.2009-0289","article-title":"Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis","volume":"15","author":"Pulte","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2025.102839_bb0350","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2147\/CIA.S365495","article-title":"Geriatric radiation oncology: what we know and what can we do better?","volume":"18","author":"Roeder","year":"2023","journal-title":"Clin Interv Aging"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0355","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hed.26548","article-title":"Treatment tolerability and outcomes in elderly patients with head and neck cancer","volume":"43","author":"Dickstein","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.jgo.2025.102839_bb0360","doi-asserted-by":"crossref","first-page":"S789","DOI":"10.1016\/j.annonc.2021.08.1274","article-title":"864MO role of geriatric assessment in tailoring treatment of locally advanced head and neck cancer: the ELDERLY study","volume":"32","author":"Bossi","year":"2021","journal-title":"Ann Oncol"},{"issue":"15_suppl","key":"10.1016\/j.jgo.2025.102839_bb0365","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.1200\/JCO.2019.37.15_suppl.11541","article-title":"ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC)","volume":"37","author":"Mertens","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0370","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz252.002","article-title":"Personalized treatment according to geriatric assessment in first-line recurrent and\/or metastatic (R\/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials","volume":"30","author":"Guigay","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0375","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2020.11.023","article-title":"Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation","volume":"154","author":"Ruhle","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0380","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00405-021-06786-6","article-title":"A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma","volume":"279","author":"Zhou","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"22","key":"10.1016\/j.jgo.2025.102839_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225536","article-title":"Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation","volume":"14","author":"Haehl","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10166","key":"10.1016\/j.jgo.2025.102839_bb0390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"10166","key":"10.1016\/j.jgo.2025.102839_bb0395","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jgo.2025.102839_bb0400","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12032-019-1292-y","article-title":"Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma","volume":"36","author":"De Felice","year":"2019","journal-title":"Med Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0405","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC group","volume":"156","author":"Lacas","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102839_bb0410","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2014.01.053","article-title":"Effectiveness of chemoradiation for head and neck cancer in an older patient population","volume":"89","author":"VanderWalde","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0415","first-page":"933","article-title":"Split-course accelerated hypofractionated radiotherapy (SCAHRT): a safe and effective option for head and neck cancer in the elderly or infirm","volume":"36","author":"Bledsoe","year":"2016","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0420","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jgo.2020.10.006","article-title":"Advanced head and neck cancer in older adults: results of a short course accelerated radiotherapy trial","volume":"12","author":"Ferro","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2025.102839_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103994","article-title":"Dose and volume de-escalation of radiotherapy in head and neck cancer","volume":"186","author":"Garcia-Anaya","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.jgo.2025.102839_bb0430","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/cncr.29742","article-title":"Glioblastoma care in the elderly","volume":"122","author":"Jordan","year":"2016","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jgo.2025.102839_bb0435","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0440","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.jgo.2025.102839_bb0445","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0450","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstrom","year":"2012","journal-title":"Lancet Oncol"},{"issue":"35","key":"10.1016\/j.jgo.2025.102839_bb0455","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","article-title":"International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and\/or frail patients with newly diagnosed glioblastoma multiforme","volume":"33","author":"Roa","year":"2015","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2025.102839_bb0460","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jgo.2025.102839_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101509","article-title":"Validation of the comprehensive geriatric assessment as a predictor of mortality in elderly glioblastoma patients","volume":"11","author":"Lombardi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.jgo.2025.102839_bb0470","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.clon.2020.06.011","article-title":"Palliative radiation therapy in older adults with cancer: age-related considerations","volume":"32","author":"O\u2019Donovan","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"21","key":"10.1016\/j.jgo.2025.102839_bb0475","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2019.17913","article-title":"Effect of single-fraction vs multifraction radiotherapy on ambulatory status among patients with spinal canal compression from metastatic cancer: the SCORAD randomized clinical trial","volume":"322","author":"Hoskin","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0480","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.jgo.2025.102839_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2023.06.007","article-title":"Palliative radiotherapy for haemostasis in malignancy: a systematic review","volume":"35","author":"Song","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"10.1016\/j.jgo.2025.102839_bb0490","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ijrobp.2021.07.034","article-title":"Rapid access palliative radiation therapy clinics: the evidence is there, but where are the clinics? An Australian and New Zealand perspective","volume":"111","author":"Roos","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.jgo.2025.102839_bb0495","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.clon.2020.08.002","article-title":"Rapid access palliative radiotherapy programmes","volume":"32","author":"Dennis","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.jgo.2025.102839_bb0500","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jgo.2018.09.009","article-title":"The role of personalized interventional radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer","volume":"10","author":"Lancellotta","year":"2019","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2025.102839_bb0505","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.brachy.2022.07.008","article-title":"Systematic review of brachytherapy for symptom palliation","volume":"21","author":"Jooya","year":"2022","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.jgo.2025.102839_bb0510","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic radiation for the comprehensive treatment of oligometastases (SBRT-COMET): extended long-term outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.jgo.2025.102839_bb0515","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with Brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2025.102839_bb0520","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825006551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825006551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:36:44Z","timestamp":1774057004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406825006551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1879406825006551"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102839","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of current best practice in radiation oncology for older adults with cancer: Updates from the International Society of Geriatric Oncology (SIOG) Task Force","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102839"}}